Welcome to our dedicated page for Raytech Holding SEC filings (Ticker: RAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Raytech Holding Limited (NASDAQ: RAY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. Raytech files reports such as its annual report on Form 20-F and current reports on Form 6-K, which contain detailed information about its business in personal care electrical appliances, financial performance and capital markets activities.
Through these filings, investors can review Raytech’s revenue breakdown by product series, including hair styling, trimmer, nail care, eyelash curler, other personal care appliances and sales of tooling. The filings also present merchandise costs, selling, general and administrative expenses, income from operations, net income and cash and cash equivalents, along with balance sheet items such as total current assets, total current liabilities and net current assets as of the reporting dates.
Raytech’s SEC reports further document equity and capital market transactions, including its initial public offering of ordinary shares on the Nasdaq Capital Market, the closing of the underwriters’ over-allotment option, and a subsequent best efforts public offering registered on Form F-1. Filings on Form 6-K describe events such as the pricing and closing of these offerings, the use of proceeds for potential acquisitions, trading business expansion, marketing, sales and product development, and general working capital, as stated by the company.
Investors can also find filings describing Nasdaq listing compliance matters and corporate actions. Raytech has filed a Form 6-K disclosing receipt of a Nasdaq notification regarding minimum bid price deficiency under Listing Rule 5550(a)(2), and another Form 6-K detailing a 16-for-1 share consolidation approved by the board, including changes to authorized share capital, par value and the effective date on the Nasdaq Capital Market. These documents explain how the share consolidation affects the number of issued and outstanding ordinary shares and confirms that the stock continues to trade under the symbol “RAY” with a new CUSIP number.
On Stock Titan, Raytech’s SEC filings are accompanied by AI-powered summaries that highlight key points from lengthy documents such as the Form 20-F and Form 6-Ks. This helps users quickly understand important disclosures on revenue composition, cost structure, cash position, equity changes and listing status, while maintaining direct access to the full text of each filing for deeper review.
Raytech Holding Limited filed a Form 6-K providing unaudited interim results for the six months ended September 30, 2025. Revenue was HKD 37,578,932 and net income was HKD 4,749,875, producing basic and diluted earnings per share of HKD 2.48, all retroactively adjusted for a share consolidation effective November 7, 2025.
As of September 30, 2025, Raytech reported total assets of HKD 146,381,084, including cash and cash equivalents of HKD 121,544,270, against total liabilities of HKD 28,768,414 and shareholders’ equity of HKD 117,612,670. During the period, a follow-on offering issued 1,624,062 ordinary shares on July 1, 2025, contributing HKD 35,900,778 and increasing issued and outstanding shares to 2,724,880.
Raytech Holding Limited reports that directors Chun Yin Ling and Wan Venus Li resigned from the board, with Ms. Li also leaving the Audit, Compensation, and Nominating and Corporate Governance Committees. Both stated their resignations were not due to any disagreement with management or the board and that they have no claims against the company or its stakeholders.
The board appointed Tianfu Yuan as a director to replace Mr. Ling and Shibin Wang as an independent director to replace Ms. Li. Dr. Wang also joins the Audit and Compensation Committees and becomes Chairperson of the Nominating and Corporate Governance Committee, and the company believes he qualifies as an independent director under Nasdaq and SEC rules. Raytech entered into offer letters and indemnity agreements with Mr. Yuan and Dr. Wang, under which Dr. Wang will receive annual cash compensation of $14,400, payable quarterly, while Mr. Yuan will not be compensated. The 6-K is incorporated by reference into Raytech’s effective Form F-3 registration statement.
Raytech Holding Limited filed Amendment No. 2 to its Form F-3 shelf registration statement, which is described as being filed solely to add new exhibits and update the exhibit index. The amendment adds legal opinions on the validity of the ordinary shares, warrants, rights and units being registered, along with consents from the company’s auditors and counsel, while leaving the previously filed prospectus and all other parts of the registration statement unchanged.
The document also outlines how British Virgin Islands law permits broad indemnification of directors and officers in Raytech’s constitutional documents, subject to good-faith and public-policy limits, and notes the SEC’s view that indemnification for Securities Act liabilities is unenforceable. In addition, Raytech includes the standard Form F-3 undertakings regarding post-effective amendments, incorporation by reference and the treatment of future prospectuses and annual reports as new offerings.
Raytech Holding Limited announced a 16-for-1 reverse stock split of its ordinary shares, effective on the Nasdaq Capital Market at the open on November 7, 2025. Every sixteen issued and unissued ordinary shares at par value US$0.00000625 will be consolidated into one ordinary share at par value US$0.0001, with fractional shares rounded up to the nearest whole share.
As a result, authorized share capital will change from 8,000,000,000 ordinary shares at par US$0.00000625 to 500,000,000 ordinary shares at par US$0.0001. Each shareholder’s percentage ownership and proportional voting power remain the same, subject to fractional share adjustments. The shares will continue trading under the symbol RAY, with a new CUSIP G7385S119 effective on the same date.
Raytech Holding Limited received a Nasdaq notice that its ordinary shares failed the Minimum Bid Price Rule after trading below
Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, until
If compliance is not achieved by
The filing amends a prior Schedule 13G to report that Tim Hoi Ching, the CEO, Chairman and a director of Raytech Holding Limited, sold 4,971,158 ordinary shares in open-market transactions on August 27-28, 2025. After these sales he reports beneficial ownership of 7,828,842 ordinary shares, representing 18.0% of the 43,598,083 shares outstanding. The stated reason for the sales was personal portfolio rebalancing and to generate additional cash flow. No related contracts, arrangements, or legal proceedings are disclosed and the sales were made for purchasers with personal funds.
Raytech Holding Limited submitted an amended Form 144 (144/A) reporting an intended sale of 5,957,725 ordinary shares on Nasdaq through Huatai Financial Holdings (Hong Kong) Limited with an aggregate market value of $15,609,239.50. The proposed block represents approximately 13.7% of the company's 43,598,083 shares outstanding and is listed with an approximate sale date of 07/30/2025. The securities were acquired on 06/24/2022 in a share issuance of 12,800,000 shares from Raytech Holding Limited and were paid in cash. The filing reports nothing to report for securities sold in the past three months. The filer also certifies they are not aware of any undisclosed material adverse information; this submission is an amendment to a prior Form 144.
Raytech Holding Limited submitted a Form 144/A reporting a proposed sale of 800,000 ordinary shares through Huatai Financial Holdings (Hong Kong) Limited as broker. The filing lists an aggregate market value of $2,208,000 and indicates 43,598,083 shares outstanding, with an approximate sale date of 08/05/2025. The shares were acquired on 09/08/2022 by private transfer from Raytech Holding Limited and were paid for in cash.
The filing states there were no securities sold by the filer in the past three months and includes the seller's representation that they do not possess undisclosed material adverse information about the issuer. The notice follows Rule 144 disclosure procedures and records the broker, acquisition details, and the seller's certification.
Rule 144 notice: the filer plans to sell 800,000 ordinary shares on the Nasdaq Capital Market via Everbright Securities Investment Services (HK) Limited. The shares carry an aggregate market value of $2.208 million and account for roughly 1.8 % of the 43,598,083 shares outstanding. The anticipated sale date is 08/05/2025.
The securities were originally acquired for cash in a private transfer on 09/08/2022. No other sales have been reported by the seller during the past three months. By signing Form 144, the seller certifies that no material non-public adverse information exists and affirms compliance with Rule 10b5-1, if applicable.
Raytech Holding Ltd. (RAY) – Form 144 notice
An unidentified insider plans to dispose of up to 5,957,725 ordinary shares through Everbright Securities Investment Services (HK) Ltd. on Nasdaq around 30 Jul 2025. The block equals roughly 13.7 % of the 43,598,083 shares outstanding and carries an aggregate market value of US$15.6 million. The shares were originally issued for cash on 24 Jun 2022. The filer reports no other sales in the past three months and certifies that no non-public adverse information is known. No operational or earnings data accompanies the filing; the document solely signals a potential supply overhang for RAY shares.
FAQ
What is the current stock price of Raytech Holding (RAY)?
What is the market cap of Raytech Holding (RAY)?
